The sporogonous of Plasmodium vivax in Anopheles mosquitoes as a system for evaluating the prophylactic and curative capabilities of potential antimalarial compounds.
D000818:Animals; D000852:Anopheles / Q000187:drug effects; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control; D009285:Naphthoquinones / Q000627:therapeutic use; D010118:Oxytetracycline / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D010966:Plasmodium vivax / Q000187:drug effects / Q000254:growth & development*; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011796:Quinacrine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use
D000962:Antimalarials; D009285:Naphthoquinones; D011725:Pyridines; D011804:Quinolines; D013882:Thiosemicarbazones; D013411:Sulfadiazine; D002738:Chloroquine; D011803:Quinine; D011796:Quinacrine; D011319:Primaquine; D010400:Penicillin G; D002727:Proguanil; D010118:Oxytetracycline; D011739:Pyrimethamine